Skip to main content
Premium Trial:

Request an Annual Quote

AP Biotech Acquires Danish Supplier of Protein Synthesis and Separation Equipment

NEW YORK, July 23 – Amersham Pharmacia Biotech has acquired Dan-Process, a Danish supplier of protein synthesis and chromatography systems, from Pantax, its parent company, Amersham said Monday.

Financial details were not disclosed. 

Dan-Process manufactures equipment for the benchtop and large scale synthesis of polypeptides, including fermentation reactors, and chromatography systems for purifying peptides and peptide hormones. 

Peder Dahl, the founder of Dan-Process, will continue to run the day-to-day operations of the company. AP Biotech, of Piscataway, NJ, will sell Dan-Process’ products through its global sales force.

"The acquisition of Dan-Process strengthens our bioprocess portfolio for the purification of peptides and peptide hormones and enhances our ability to offer a complete system solution to our biopharmaceutical customers," Peter Ehrenheim, executive vice president of separations at AP Biotech, said in a statement.

AP Biotech filed for an initial public offering last October, but has postponed the transaction because of market conditions.  
The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.